Jesse Reynolds, MS
Assistant Director of Applied BiostatisticsDownloadHi-Res Photo
Cards
Additional Titles
Biostatistician
Contact Info
About
Copy Link
Titles
Assistant Director of Applied Biostatistics
Biostatistician
Departments & Organizations
- All Institutions
Education & Training
- MS
- Southern Connecticut State University, Research Statistics and Measurement (2007)
- BS
- Southern Connecticut State University, Sociology (2002)
Research
Copy Link
Research at a Glance
Yale Co-Authors
Frequent collaborators of Jesse Reynolds's published research.
Publications Timeline
A big-picture view of Jesse Reynolds's research output by year.
James Dziura, MPH, PhD
E. Jennifer Edelman, MD, MHS, BS
Alfred Lee, MD, PhD
Ami Belmont, MD
Cassius Iyad Ochoa Chaar, MD, MPH, MS, RPVI
Geliang Gan, MPH, PhD
21Publications
549Citations
Publications
2026
Penicillin Allergy Labels are Associated with Carbapenem/Monobactam Antibiotic Utilization among Patients Undergoing Hematopoietic Stem Cell Transplants
Belmont A, Reynolds J, Stone C, Valente M, Dziura J, Gehan D, Malinis M, Phillips E, Sarpong D, Seropian S, Edelman E. Penicillin Allergy Labels are Associated with Carbapenem/Monobactam Antibiotic Utilization among Patients Undergoing Hematopoietic Stem Cell Transplants. The Journal Of Allergy And Clinical Immunology 2026, 157: ab108. DOI: 10.1016/j.jaci.2025.12.320.Peer-Reviewed Original Research
2025
Prevalence and patient-level factors associated with common antibiotic allergy labels among patients undergoing hematopoietic stem cell transplants: a cross-sectional study
Belmont A, Reynolds J, Stone C, Dziura J, Malinis M, Phillips E, Sarpong D, Seropian S, Edelman E. Prevalence and patient-level factors associated with common antibiotic allergy labels among patients undergoing hematopoietic stem cell transplants: a cross-sectional study. The Journal Of Allergy And Clinical Immunology In Practice 2025, 14: 289-292.e2. PMID: 41161669, PMCID: PMC12753012, DOI: 10.1016/j.jaip.2025.10.016.Peer-Reviewed Original ResearchAltmetricPhase 2 trial of dual EGFR inhibition with cetuximab and afatinib in patients with recurrent/metastatic head and neck squamous cell cancers (HNSCC).
Bhatia A, Wei W, Chiorazzi M, Deshpande H, Reynolds J, Gehan D, Tara H, Newton B, Verma A, Sayed Z, Roche A, Mehra S, Judson B, Yarbrough W, Burtness B. Phase 2 trial of dual EGFR inhibition with cetuximab and afatinib in patients with recurrent/metastatic head and neck squamous cell cancers (HNSCC). Journal Of Clinical Oncology 2025, 43: 6023-6023. DOI: 10.1200/jco.2025.43.16_suppl.6023.Peer-Reviewed Original ResearchCitationsConceptsHead and neck squamous cell cancerEpidermal growth factor receptorMedian overall survivalCombination of cetuximabAdverse eventsHuman epidermal growth factor receptor (HER)-2Recurrent/metastatic head and neck squamous cell cancerRefractory to platinum-based chemotherapyEpidermal growth factor receptor targetEpidermal growth factor receptor inhibitionSingle-arm phase II trialPhosphorylated epidermal growth factor receptorCommonest adverse eventsP16+ diseaseProgression-free survivalImmune checkpoint therapyP16-positive tumorsPlatinum-based chemotherapyPrimary tumor locationPhase 2 trialPhase II trialSquamous cell cancerPost-treatment biopsiesTrials of chemotherapyEGFR inhibitor treatment
2023
Facilitation and Preferred Models for Delivering Substance Use Disorder Treatment in HIV Clinics: Results From a Multisite Randomized Trial
Muvvala S, Gan G, Morford K, Dziura J, Esserman D, Porter E, Chan P, Cornman D, Reynolds J, Yager J, Fiellin D, Edelman E. Facilitation and Preferred Models for Delivering Substance Use Disorder Treatment in HIV Clinics: Results From a Multisite Randomized Trial. Journal Of Addiction Medicine 2023, 17: e388-e391. PMID: 37934538, PMCID: PMC10726383, DOI: 10.1097/adm.0000000000001192.Peer-Reviewed Original ResearchAltmetricMeSH Keywords and ConceptsConceptsOpioid use disorderAlcohol use disorderTobacco use disorderHIV clinicUse disordersAddiction treatmentSubstance use disorder treatmentUse disorder treatmentMaintenance phaseRandomized trialsStaff preferencesImproved outcomesMultisite Randomized TrialImplementation facilitationDisorder treatmentControl phaseClinicCliniciansTreatment modelTreatmentDisordersSignificant differencesInterventionHigher proportionAddiction treatment modelsUse of an Automated Bilingual Digital Health Tool to Reduce Unhealthy Alcohol Use Among Latino Emergency Department Patients
Vaca F, Dziura J, Abujarad F, Pantalon M, Hsiao A, Reynolds J, Maciejewski K, Field C, D’Onofrio G. Use of an Automated Bilingual Digital Health Tool to Reduce Unhealthy Alcohol Use Among Latino Emergency Department Patients. JAMA Network Open 2023, 6: e2314848. PMID: 37219901, PMCID: PMC10208138, DOI: 10.1001/jamanetworkopen.2023.14848.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsStandard care groupNumber of bingesEmergency department patientsStandard careED patientsCare groupBrief interventionDepartment patientsAlcohol screeningDisease burdenUnhealthy drinkingDigital health toolsLevel II trauma centerHealth toolsParticipants 25 yearsAlcohol-related health disparitiesTertiary care centerAdverse health behaviorsUnhealthy alcohol useHigh disease burdenAlcohol use disorderTimeline followback methodEmergency medical careSelf-reported numberHigh-risk drinking
2022
Effect of Implementation Facilitation to Promote Adoption of Medications for Addiction Treatment in US HIV Clinics
Edelman EJ, Gan G, Dziura J, Esserman D, Porter E, Becker WC, Chan PA, Cornman DH, Helfrich CD, Reynolds J, Yager JE, Morford KL, Muvvala SB, Fiellin DA. Effect of Implementation Facilitation to Promote Adoption of Medications for Addiction Treatment in US HIV Clinics. JAMA Network Open 2022, 5: e2236904. PMID: 36251291, PMCID: PMC9577676, DOI: 10.1001/jamanetworkopen.2022.36904.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsTobacco use disorderHIV clinicOpioid use disorderUse disordersAlcohol use disorderAddiction treatmentControl periodImplementation facilitationAdoption of medicationsMulticomponent implementation strategyProvision of MOUDUS HIV clinicsMaintenance periodElectronic health record dataHealth record dataEvaluation periodAdult patientsMean ageClinical trialsMAIN OUTCOMEClinicMOUDPatientsDisordersPatient incentivesLGBQ-Affirmative Cognitive-Behavioral Therapy for Young Gay and Bisexual Men’s Mental and Sexual Health: A Three-Arm Randomized Controlled Trial
Pachankis JE, Harkness A, Maciejewski KR, Behari K, Clark KA, McConocha E, Winston R, Adeyinka O, Reynolds J, Bränström R, Esserman DA, Hatzenbuehler ML, Safren SA. LGBQ-Affirmative Cognitive-Behavioral Therapy for Young Gay and Bisexual Men’s Mental and Sexual Health: A Three-Arm Randomized Controlled Trial. Journal Of Consulting And Clinical Psychology 2022, 90: 459-477. PMID: 35482652, PMCID: PMC9446477, DOI: 10.1037/ccp0000724.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsHIV transmission risk behaviorsTransmission risk behaviorsHIV testingCognitive behavioral therapyRisk behaviorsSexual healthTransdiagnostic cognitive-behavioral therapyEffect sizeYoung sexual minority menSecondary outcomesPrimary outcomeControl conditionThree-armLarge effect sizesSexual minority menModerate benefitFirst interventionNonsignificant differenceStatistical significanceYoung gayCounselingMonthsGreater reductionTherapyOutcomes
2020
Exenatide extended release in patients with type 1 diabetes with and without residual insulin production
Herold KC, Reynolds J, Dziura J, Baidal D, Gaglia J, Gitelman SE, Gottlieb PA, Marks J, Philipson LH, Pop‐Busui R, Weinstock RS. Exenatide extended release in patients with type 1 diabetes with and without residual insulin production. Diabetes Obesity And Metabolism 2020, 22: 2045-2054. PMID: 32573927, PMCID: PMC8009602, DOI: 10.1111/dom.14121.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsExenatide extended releaseResidual insulin productionBeta-cell functionType 1 diabetesC-peptidePlacebo groupPrimary outcomeWeek 12ER groupInsulin productionDetectable C-peptide levelsResidual beta-cell functionGLP-1 receptor agonistsRandomized placebo-controlled trialExtended releaseTotal insulin doseMean HbA1c levelPlacebo-controlled trialC-peptide levelsDetectable levelsCell functionShort-term improvementHbA1c levelsStudy drugAdverse eventsQuality and Publication of Emergency Medicine Trials Registered in ClinicalTrials.gov
Calvocoressi L, Reynolds J, Johnson B, Warzoha MM, Carroll M, Vaca FE, Post L, Dziura J. Quality and Publication of Emergency Medicine Trials Registered in ClinicalTrials.gov. Western Journal Of Emergency Medicine 2020, 21: 295-303. PMID: 32191186, PMCID: PMC7081876, DOI: 10.5811/westjem.2019.12.44096.Peer-Reviewed Original ResearchCitationsMeSH Keywords and ConceptsConceptsClinical trialsEM trialsKaplan-Meier curvesLog-rank testNational clinical trialClinical trial researchChi-square testEM studiesTrial qualityInterventional trialsPeer-reviewed journalsMedicine trialsNeurological conditionsLarger sample sizeTrial researchStudy characteristicsStudy periodTrialsNational InstituteSubspecialty areasBlindingPeriodic assessmentDescriptive statisticsHigher proportionIndustry funding
2019
Project ESTEEM protocol: a randomized controlled trial of an LGBTQ-affirmative treatment for young adult sexual minority men’s mental and sexual health
Pachankis JE, McConocha EM, Reynolds JS, Winston R, Adeyinka O, Harkness A, Burton CL, Behari K, Sullivan TJ, Eldahan AI, Esserman DA, Hatzenbuehler ML, Safren SA. Project ESTEEM protocol: a randomized controlled trial of an LGBTQ-affirmative treatment for young adult sexual minority men’s mental and sexual health. BMC Public Health 2019, 19: 1086. PMID: 31399071, PMCID: PMC6688287, DOI: 10.1186/s12889-019-7346-4.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsCo-occurring health risksYoung gayHIV riskSubstance useHealth disparitiesCommunity mental health treatmentMental healthAbsence of PrEPUndetectable viral loadHigh-risk groupSexual health problemsCondomless anal sexSkills-building interventionMental health treatmentAdult Sexual Minority MenSubstance use problemsBisexual men’s healthSecondary outcomesHIV counselingHIV infectionPrEP uptakePrimary outcomeViral loadEvidence-based practicePsychiatric morbidity
Academic Achievements & Community Involvement
Copy Link
Honors
honor Linda Lorimer Award for Distinguished Service
11/14/2022Yale University AwardYale UniversityDetailsUnited States
News
Copy Link
Get In Touch
Copy Link
Contacts
Academic Office Number
Locations
300 George Street
Academic Office
New Haven, CT 06511